Position in MRK
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$694,799
+$25,506 QoQ
Shares Held
5,407
-2.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.65%
of 13F equity value
Holder Rank
#2,420
of 3,769 holders
Holding Since
Dec 2024
7 quarters on record
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026LEIGH BALDWIN & CO., LLC holds $5,076,288 across 8 Drug Manufacturers - General names. MRK ranks #2 (13.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
1,112 | $1,333,766 | |
| 2 | MRK |
Merck & Co., Inc.
This page
|
5,407 | $694,799 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
4,769 | $602,515 | |
| 4 | JNJ |
Johnson & Johnson
|
2,262 | $574,480 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
9,200 | $530,104 | |
| 6 | PFE |
Pfizer Inc
|
19,135 | $460,770 | |
| 7 | ABBV |
AbbVie Inc.
|
1,761 | $443,138 | |
| 8 | AMGN |
Amgen Inc
|
1,206 | $436,716 |
All Filings in MRK
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $694,799 | 5,407 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $669,293 | 5,564 | Shares | Sole | 2026-05-20 | |
| 2025-12-31 | $586,087 | 5,568 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $1,862,070 | 22,186 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,692,519 | 21,381 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $1,890,525 | 21,062 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $2,130,364 | 21,415 | Shares | Sole | 2025-02-25 | |
| No filing history on record for this holder in this stock. | ||||||